The DOI matches its Crossref record.
Toxocariasis in humans: clinical expression and treatment dilemma
Abstract
A new scheme of clarifying clinical forms of toxocariasis is proposed to include: (i) systemic forms: classical VLM and incomplete VLM; (ii) compartmentalized forms: ocular and neurological toxocariasis; (iii) covert toxocariasis; and (iv) asymptomatic toxocariasis. The following markers are helpful in defining clinical forms namely, patient characteristics and history, clinical symptoms and signs, positive serology, eosinophilia and increased levels of IgE. Amongst the available drugs albendazole is the most commonly used, although other benzimidazole compounds have a similar efficacy. The recommended dose of albendazole is 15 mg kg-1 body weight daily for 5 days and in some cases with VLM syndrome the treatment needs to be repeated. An evaluation of treatment efficacy can be made by observing a rise in eosinophilia within a week followed by any improvement in clinical symptoms and signs, lower eosinophilia and serological tests taken over a period of at least 4 weeks. In addition to clinical rationales for the specific treatment of VLM and OLM, preventive treatment needs to be considered bearing in mind the increasing risk of larvae localizing in the brain during the course of an infection. To reduce migration of Toxocara larvae a single course of albendazole is suggested in cases where eosinophilia and serology are at least moderately positive.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The epidemiology and public health importance of toxocariasis: A zoonosis of global importance
Macpherson, C. N. L. (2013) · International Journal for Parasitology · doi:10.1016/j.ijpara.2013.07.004 · Cited by 477
Ma, G., Holland, C. V., Wang, T., Hofmann, A., Fan, C.-K., Maizels, R. M., Hotez, P. J., & Gasser, R. B. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30331-6 · Cited by 420
Rubinsky-Elefant, G., Hirata, C. E., Yamamoto, J. H., & Ferreira, M. U. (2010) · Annals of Tropical Medicine & Parasitology · doi:10.1179/136485910x12607012373957 · Cited by 390
“The clinical spectrum of toxocariasis in humans, which varies from asymptomatic infection to severe organ injury, is deter- mined by the parasite load, the sites of larval migration, and the host’s inflammatory response (Pawlowski, 2001).”
BackgroundHotez, P. J., & Wilkins, P. P. (2009) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000400 · Cited by 283
Toxocariasis: a silent threat with a progressive public health impact
Chen, J., Liu, Q., Liu, G.-H., Zheng, W.-B., Hong, S.-J., Sugiyama, H., Zhu, X.-Q., & Elsheikha, H. M. (2018) · Infectious Diseases of Poverty · doi:10.1186/s40249-018-0437-0 · Cited by 274
Human toxocariasis – A look at a neglected disease through an epidemiological ‘prism’
Rostami, A., Ma, G., Wang, T., Koehler, A. V., Hofmann, A., Chang, B. C. H., Macpherson, C. N., & Gasser, R. B. (2019) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2019.104002 · Cited by 143
The prevalence of Toxocara cati in domestic cats in Mexico City
Martı́nez-Barbabosa, I., Vázquez Tsuji, O., Cabello, R. R., Cárdenas, E. M. G., & Chasin, O. A. (2003) · Veterinary Parasitology · doi:10.1016/s0304-4017(03)00038-4 · Cited by 49
Metadata
- Authors
- Pawlowski, Z.
- Venue
- Journal of Helminthology
- Publisher
- Cambridge University Press (CUP)
- Published
- 2001-12
- Volume
- 75
- Issue
- 4
- Pages
- 299-305
- ISSN
- 0022-149X (ISSN-L)
- 1475-2697
- OpenAlex
- W2114746640
- Cited by
- 241
- References
- 0
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.